Fortis Healthcare Limited has informed the Exchange about Presentation
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fortis Healthcare shared its investor presentation for the JP Morgan 2026 Healthcare Conference. Consolidated revenue for H1FY26 stood at Rs 44,982 crore ($519 Mn) with operating EBITDA margin of 23.3%, up from 20.4% in FY20. The hospital business delivered Rs 38,119 crore in H1FY26 revenue at a 22.5% EBITDA margin, with occupancy steady at 70% and ARPOB up 4.2% YoY to Rs 24.9 lakh. The diagnostics business posted Rs 7,684 crore in revenue at a strong 24.6% EBITDA margin. The company announced plans to add 3,200+ beds (including O&M) between FY25 and FY30, targeting a 10.7% CAGR, with multiple recent acquisitions and O&M agreements in Bangalore, Greater Noida, Lucknow, Jalandhar, and a Gleneagles tie-up. Balance sheet remains comfortable with net debt-to-equity at 0.23x.
Positive for investors — the presentation underscores strong margin expansion, robust growth trajectory, and a clear multi-year capacity addition roadmap. Recent acquisitions and O&M deals signal aggressive inorganic growth, supported by a healthy balance sheet that provides ample headroom for further expansion.